Senior insider sale
EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$9.09M
259.81K shares
What this filing means
KALIF ELIYAHU SHARON plans to sell 259.81K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $9.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/11/2026ACC: 0001973379-26-000227
Officer· EVP, Chief Financial Officer
Since Dec 2019
259.81K
Shares to sell
$9.09M
Approx. market value
106.56K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
SHARES FROM ROLLOVER
COMPENSATION
3/4/2026
33.51KSHARES FROM ROLLOVER
COMPENSATION
3/3/2026
24.90KSHARES FROM ROLLOVER
COMPENSATION
3/3/2026
24.90KSHARES FROM ROLLOVER
COMPENSATION
3/4/2025
23.25KTotal acquired106.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | SHARES FROM ROLLOVER COMPENSATION | 33.51K | — |
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 24.90K | — |
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 24.90K | — |
3/4/2025 | SHARES FROM ROLLOVER COMPENSATION | 23.25K | — |
| Total | 106.56K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
153.25K
Market value
$5.46M
5/14/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
106.56K
Market value
$3.63M
6/11/2026
Total
Units
259.81K
Value
$9.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/14/2026 | 153.25K | $5.46M | — | Completed |
| Planned — Approximate Date | ||||
6/11/2026 | 106.56K | $3.63M | NYSE | Planned |
| Total | 259.81K | $9.09M | ||